Mirae Asset Global Etfs Holdings Ltd. Poseida Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 141,339 shares of PSTX stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
141,339
Previous 151,454
6.68%
Holding current value
$1.34 Million
Previous $433,000
213.16%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PSTX
# of Institutions
119Shares Held
37.8MCall Options Held
370KPut Options Held
394K-
Pentwater Capital Management LP Naples, FL8.63MShares$81.9 Million0.95% of portfolio
-
Nomura Holdings Inc Tokyo, M05.12MShares$48.6 Million0.07% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.83MShares$36.4 Million0.0% of portfolio
-
Alpine Associates Management Inc. Englewood Cliffs, NJ2.02MShares$19.2 Million1.2% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...